A cortex és hippocampus génterápiájának lehetőségei rekombináns adenovírussal

Translated title of the contribution: Possibilities of gene therapy with recombinant adenovirus in the cortex and hippocampus

Péter Koska, Attila Valikovics, Éva Kiss-Tóth, Adrienn Szalai, Zoltán Nagy, Bertalan Fodor

Research output: Contribution to journalArticle


Background and purpose - Neurodegenerative diseases eg. ischemic stroke causes lifelong disabilities in cognitive functions and movement, furthermore high frequency of death. Antiapoptotic, or growth factor gene targeting to cortical structures could be a useful tool for neuroprotection in ischemic brain diseases. In present study we examined the feasibility of the gene therapy of the cortex and hippocampus via transfecting brain with recombinant adenovirus containing LacZ reporter gene in normal and postischemic condition. Since translation of proteins can be inhibited following ischemia by the phosphorylation of ribosomal subunit eIF2α, phosphor-eIF2α immunohystochemistry were performed. Methods - Our adenovirus vector was introduced via the cisterna magna into control and postischemic gerbil brain. After 48 hours of transfection the brains were examined for X-gal staining. LacZ expressing cells showed blue colour. Five min. transient global ischemia was induced by clipping the vertebral and carotid arteries of gerbil. Phosphor-eIF2α immunohystochemistry were performed following 48 hours of ischemia. Results - Administration of adenoviral vector resulted in transfection of hippocampal CA1, CA2, CA3 cell layers while gyrus dentatus remained untransfected. Cortical pyramidal cell layers were also transfeded. In postischemic brain the lack of LacZ gene expression were detected in the CA1 and CA2 layer of hippocampus. Ischemia caused eIF2α phosphorylation in hippocampal CA1, CA2, CA3 and most neuronal layers in the cortex. Conclusion - Introducing adenovirus vector via the cisterna magna may results in effective gene therapy of cortex and hippocampus. To develop effective gene therapy in postischemic hippocampal CA1 and CA2 cell layers needs further investigation. eIF2α phosphorylation probably doesn't interfere with transgene expression.

Translated title of the contributionPossibilities of gene therapy with recombinant adenovirus in the cortex and hippocampus
Original languageHungarian
Pages (from-to)184-189
Number of pages6
JournalIdeggyogyaszati szemle
Issue number5-6
Publication statusPublished - May 30 2013

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Fingerprint Dive into the research topics of 'Possibilities of gene therapy with recombinant adenovirus in the cortex and hippocampus'. Together they form a unique fingerprint.

  • Cite this

    Koska, P., Valikovics, A., Kiss-Tóth, É., Szalai, A., Nagy, Z., & Fodor, B. (2013). A cortex és hippocampus génterápiájának lehetőségei rekombináns adenovírussal. Ideggyogyaszati szemle, 66(5-6), 184-189.